REDWOOD CITY, Calif.--(BUSINESS WIRE)--Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced the publication ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that The ...

Arrayus Technologies has announced the Health Canada approval for its magnetic resonance imaging (MRI)-guided focused ultrasound therapy system for uterine fibroid tissue ablation. The approval ...

New York, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Uterine Fibroid Treatment Device Market Research Report by ...

2014 Fierce 15 company Gynesonics has unveiled long-term follow-up data, spanning more than five years, that tracks the durability of its incisionless ablation treatment for uterine fibroids. The ...

As the FDA has taken steps to limit the use of laparoscopic power morcellators in gynecological procedures, surgeons have had to seek out other methods to perform hysterectomies and myomectomies, or ...

I read with interest the article by Neis et al. (1). The attentive reader will have regretted the absence of a treatment approach increasingly used as a uterus-preserving surgical procedure both ...

Please provide your email address to receive an email when new articles are posted on . Live birth rates were similar for women with uterine fibroids who underwent radiofrequency ablation or ...

VIENNA, Austria — Advances in magnetic resonance-guided focused ultrasound technology have led to improved results for uterine fibroid ablation, with few safety concerns, a new study shows. "This ...

As a nurse who has worked for 18 years at a hospital’s obstetrics and gynaecology (ob-gyn) unit, Nurunneesa (not her real name) should have been well aware of issues related to reproductive health.